Advertisement

Author: Janine Anthes

November 2019 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Asthma Exacerbations May Worsen Pregnancy Outcomes WEDNESDAY, Nov. […]

Read More

November 2019 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Outcomes Poorer With New U.S. Donor Heart Allocation […]

Read More

November 2019 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]

Read More

November 2019 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician […]

Read More

November 2019 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for Acute […]

Read More

November 2019 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]

Read More

November 2019 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for […]

Read More

November 2019 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]

Read More

November 2019 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antimicrobial Resistance Patterns Examined for Adult, Peds HAIs […]

Read More

November 2019 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With […]

Read More

November 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With Supplemental […]

Read More

November 2019 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]

Read More

November 2019 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician Burnout […]

Read More

November 2019 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]

Read More

November 2019 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]

Read More

November 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, Very […]

Read More

November 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Study Supports PSA Screening for Male BRCA2 Carriers […]

Read More

For latest news and updates
Email-id is invalid